139 related articles for article (PubMed ID: 17129844)
1. Efficacy of adjuvant chemotherapy using oral fluorinated pyrimidines for curatively resected gastric cancer: a meta-analysis of centrally randomized controlled clinical trials in Japan.
Oba K; Morita S; Tsuburaya A; Kodera Y; Kobayashi M; Sakamoto J
J Chemother; 2006 Jun; 18(3):311-7. PubMed ID: 17129844
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant chemotherapy for gastric cancer in Japan: global and Japanese perspectives.
Sakamoto J; Morita S; Kodera Y; Rahman M; Nakao A
Cancer Chemother Pharmacol; 2004 Sep; 54 Suppl 1():S25-31. PubMed ID: 15309511
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation of clinical trials on adjuvant chemotherapy for curatively resected gastric cancer].
Kitamura M; Arai K; Iwasaki Y
Gan To Kagaku Ryoho; 1997 Aug; 24(10):1221-9. PubMed ID: 9279340
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant therapy of gastric cancer: the Japanese experience.
Fukushima M
Semin Oncol; 1996 Jun; 23(3):369-78. PubMed ID: 8658221
[TBL] [Abstract][Full Text] [Related]
5. [Overview of clinical trials on adjuvant chemotherapy for curatively resected gastric cancer].
Sasako M; Sano T; Katai H; Okajima K; Maruyama K
Gan To Kagaku Ryoho; 1994 Oct; 21 Suppl 3():384-94. PubMed ID: 7986119
[TBL] [Abstract][Full Text] [Related]
6. Impact of adjuvant chemotherapy in the long-term outcome of patients with resected gastric cancer.
Grau JJ; Martín M; Fuster J; Pera M; García-Valdecasas JC; Bombí JA; Bordas JM; Alcobendas F; Grande L; Estapé J
J Surg Oncol; 2003 Apr; 82(4):234-40. PubMed ID: 12672007
[TBL] [Abstract][Full Text] [Related]
7. [Current status and problem of adjuvant chemotherapy for curatively resected gastric cancer].
Saka M; Sasako M; Katai H; Sano T
Gan To Kagaku Ryoho; 2000 Nov; 27(13):2033-42. PubMed ID: 11103234
[TBL] [Abstract][Full Text] [Related]
8. Overview of adjuvant therapy for resected gastric cancer: differences in Japan and the United States.
Ohtsu A; Sasako M
Semin Oncol; 2005 Dec; 32(6 Suppl 9):S101-4. PubMed ID: 16399444
[TBL] [Abstract][Full Text] [Related]
9. [Gastric cancer].
Kinoshita T; Konishi M; Nakagohri T; Takahashi S; Gotouda N
Gan To Kagaku Ryoho; 2006 Mar; 33(3):313-7. PubMed ID: 16531710
[TBL] [Abstract][Full Text] [Related]
10. [Meta-analysis of 10 postoperative adjuvant chemotherapies for gastric cancer in CIH].
Nakajima T; Ota K; Ishihara S; Oyama S; Nishi M; Hamashima N
Gan To Kagaku Ryoho; 1994 Aug; 21(11):1800-5. PubMed ID: 8080299
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of adjuvant chemotherapy using tegafur-based regimen for curatively resected gastric cancer: update of a meta-analysis.
Oba K
Int J Clin Oncol; 2009 Apr; 14(2):85-9. PubMed ID: 19390937
[TBL] [Abstract][Full Text] [Related]
12. Randomized trial of adjuvant chemotherapy with mitomycin, Fluorouracil, and Cytosine arabinoside followed by oral Fluorouracil in serosa-negative gastric cancer: Japan Clinical Oncology Group 9206-1.
Nashimoto A; Nakajima T; Furukawa H; Kitamura M; Kinoshita T; Yamamura Y; Sasako M; Kunii Y; Motohashi H; Yamamoto S;
J Clin Oncol; 2003 Jun; 21(12):2282-7. PubMed ID: 12805327
[TBL] [Abstract][Full Text] [Related]
13. Low thymidylate synthase expression in the primary tumor predicts favorable clinical outcome in resected gastric cancer patients treated with adjuvant tegafur.
Grau JJ; Domingo-Domenech J; Morente V; Pera M; Garcia-Valdecasas JC; Fuster J; Bombí A; Mellado B; Albanell J; Gascón P
Oncology; 2004; 66(3):226-33. PubMed ID: 15218314
[TBL] [Abstract][Full Text] [Related]
14. [Effectiveness of precautionary chemotherapy in gastric cancer].
Rimassa L; Campagnoli E; Biancofiore G
Tumori; 2000; 86(5 Suppl 2):S5-13. PubMed ID: 11195303
[TBL] [Abstract][Full Text] [Related]
15. Clinical potential of biological response modifiers combined with chemotherapy for gastric cancer. Japanese experience.
Shibata M; Nezu T; Fujisaki S; Andou K; Tomita R; Fukuzawa M
Dig Surg; 2002; 19(4):255-60. PubMed ID: 12207066
[TBL] [Abstract][Full Text] [Related]
16. Postoperative chemotherapy for gastric cancer.
Hejna M; Wöhrer S; Schmidinger M; Raderer M
Oncologist; 2006 Feb; 11(2):136-45. PubMed ID: 16476834
[TBL] [Abstract][Full Text] [Related]
17. [Adjuvant chemotherapy using S-1 for curatively resected gastric cancer-the nationwide clinical trial].
Sasako M; Saka M; Fukagawa T; Katai H; Sano T
Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():110-6. PubMed ID: 16897984
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant therapy after curative resection for gastric cancer: meta-analysis of randomized trials.
Hermans J; Bonenkamp JJ; Boon MC; Bunt AM; Ohyama S; Sasako M; Van de Velde CJ
J Clin Oncol; 1993 Aug; 11(8):1441-7. PubMed ID: 8336183
[TBL] [Abstract][Full Text] [Related]
19. [Comparative clinical study of adjuvant postoperative chemotherapy (5-FU, Tegafur, 5-FU + MMC) in curatively resected cases of gastric cancer. Study Group on 5-FU Oral Adjuvant Chemotherapy in Gastric Cancer].
Nakajima T; Miwa K; Ohmori Y; Sakabe T; Fujii M; Kajitani T
Gan To Kagaku Ryoho; 1996 Aug; 23(9):1161-8. PubMed ID: 8751804
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant chemotherapy for gastric cancer in Japan: present status and suggestions for rational clinical trials.
Nakajima T
Jpn J Clin Oncol; 1990 Mar; 20(1):30-42. PubMed ID: 2181170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
